Biotechnology Innovation Organization

I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech

[Biotechnology Innovation Organization @IAmBiotech]

Today, BIO President and CEO John F. Crowley joined @SCClemons at the Bold Bets Healthcare Summit to discuss how the U.S. can lead the world in healthcare innovation. Crowley underscored the importance of a healthy biotech ecosystem and greater access to medicines, as well as the role that storytelling plays in raising awareness of the potential of biomedical innovation. #BiotechInnovation

[Biotechnology Innovation Organization @IAmBiotech]

Congratulations to BIO member @ShionogiUS on the FDA approval of XOCOVA, the first and only oral option to prevent COVID-19 following exposure. #BioInnovation

[Shionogi Inc. (U.S.) @ShionogiUS]

#News: The FDA has approved our oral antiviral for post-exposure prophylaxis of COVID-19 in adults and adolescents 12 years of age and older. It is the first and only oral option to help prevent COVID-19 following exposure to an infected individual. Learn more here: https://t.co/rc8mjA43zX

[Biotechnology Innovation Organization @IAmBiotech]

BIO CEO John F. Crowley will be at the Bold Bets Health Summit on Thursday, June 4 in Washington, DC, joining @SCClemons for a conversation on the future American biotech innovation and what is at stake for the patients depending on it. #BiotechInnovation

Register: https://t.co/VV2sm6VApH

[National Press Foundation @NatPress]

.@jessicanix_ of @business joins Phyllis Arthur of @IAmBiotech and Karen Sharpnack of National Association of State Immunization Coalitions for NPF's free online briefing on vaccines and the government June 10 at noon ET.

Register to join the discussion: https://t.co/mM3MiVkjYI

[Biotechnology Innovation Organization @IAmBiotech]

As we mark 50 years of biotechnology innovation, what conversations are shaping biotech's next chapter? At #BIO2026, explore 135+ sessions across 18 focus areas and hear from the leaders, innovators, policymakers, investors, and patient advocates driving the future of our industry.

View the full program and speaker lineup: https://t.co/Fp2jdXnllw

[Biotechnology Innovation Organization @IAmBiotech]

As vaccine policies continue to evolve, BIO is sponsoring an upcoming @NatPress webinar on June 10 to help bring greater clarity and context to these changes for journalists. BIO’s Phyllis Arthur will be on the panel - registration is now open!
https://t.co/Cx6ZTLlpJb

#Vaccines #BiotechInnovation

[National Press Foundation @NatPress]

To help reporters cover vaccine policy in the U.S. with accuracy and context, NPF will host a free online briefing June 10, noon ET, featuring Phyllis Arthur of @IAmBiotech and Karen Sharpnack of the National Association of State Immunization Coalitions.
https://t.co/HpoJ2nH1Kz

[Biotechnology Innovation Organization @IAmBiotech]

A historic first for patients living with HDV. Congratulations to BIO member @GileadSciences on the FDA's accelerated approval of Hepcludex, the first and only treatment for chronic hepatitis delta virus in the U.S. #BioInnovation

[Gilead Sciences @GileadSciences]

#GileadNews: The U.S. FDA has granted accelerated approval for our treatment for adults living with chronic hepatitis delta virus (HDV), making it the first and only treatment option in the United States. Read more https://t.co/ALWIhkOxeE

[Biotechnology Innovation Organization @IAmBiotech]

BIO applauds @GovernorVA's veto of legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in the Commonwealth.

As states continue exploring affordability reforms, it is critical that policies protect access for patients without undermining the innovation ecosystem responsible for developing new and lifesaving medicines. BIO remains focused on advancing solutions that strengthen patient access while preserving the scientific leadership and investment that drive American biotechnology forward.

Read more: https://t.co/4aPgRtTOxH

[Biotechnology Innovation Organization @IAmBiotech]

Expiring today -> With #BIO2026 just 1 MONTH away, don't miss out on the Advance Rates that are locking in savings for Convention attendees. Learn about the various registration packages and register today: https://t.co/BLQgTd0dRP

[Biotechnology Innovation Organization @IAmBiotech]

Last week in Raleigh, BIO’s Elizabeth Gaskins joined advocates and partners at an @ACSCAN advocacy day to support North Carolina House Bill 567, “Ensure Access to Biomarker Testing.” As precision medicine continues to advance, ensuring coverage for medically appropriate #biomarker testing is critical to helping patients access more personalized care, enable proactive care management, and reduce disparities in outcomes.

[Biotechnology Innovation Organization @IAmBiotech]

May marks both #LupusAwarenessMonth and Women’s Health Month. In the latest https://t.co/ZpbgpvzkpL story, @LupusOrg discusses the ongoing challenges facing lupus patients, the latest advances in research and treatment, and why greater awareness remains critical - particularly as lupus disproportionately affects women, especially women from historically underserved communities. Read the full story on https://t.co/ZpbgpvzkpL: https://t.co/9h63t60DIn

[Biotechnology Innovation Organization @IAmBiotech]

#MustRead -> Ahead of #BIO2026, INDY NXT driver and patient advocate @JamesRoe_IE spoke with https://t.co/ZpbgpvyMAd about managing severe asthma while competing at one of the highest levels of racing - and how his experience as a patient continues to shape his advocacy. In the conversation, Roe reflects on the role innovation and modern biotech breakthroughs have played in his own journey, why patient voices matter in driving progress, and what it means to be truly “Driven by Purpose.”

Read the full conversation on https://t.co/ZpbgpvyMAd: https://t.co/zCuw18XSjb

[Biotechnology Innovation Organization @IAmBiotech]

#MustRead in https://t.co/ZpbgpvzkpL: "What is PDUFA - and why does it matter for biotech innovators, FDA & patients?" Featuring BIO's Annetta Beauregard, the feature examines just how important the Prescription Drug User Fee Act (PDUFA) is to patients and the biotech ecosystem. Read the full piece: https://t.co/xrBu0bjXPr #PDUFA #biotech

[Biotechnology Innovation Organization @IAmBiotech]

#MustRead: Kicking off National Women’s Health Month, https://t.co/9hOxRo6BPd highlighted BIO’s panel, Capital to Commercial: The Women’s Health BIOtech Ecosystem, at the inaugural Health Executive and Research Summit in San Diego: https://t.co/XaghjxAhto

[Biotechnology Innovation Organization @IAmBiotech]

The future of biotechnology will be defined by the choices we make today – on policy, investment, and the ecosystem needed for innovation to thrive. #FightofOurLives brings forward the voices and stories that demonstrate why continued leadership in #biotech matters. Hear the stories, see the impact, understand the promise: https://t.co/4CUwHVutQo

[Biotechnology Innovation Organization @IAmBiotech]

#BIO2026 will kick off on June 22 with an AI Summit, bringing together leaders across biotechnology, manufacturing, policy, and patient advocacy to explore how AI and emerging technologies are transforming the full innovation ecosystem - from discovery and clinical development to manufacturing scale-up and global competitiveness. Learn more and register: https://t.co/56Gdt9VPmd

Sessions will examine:
- How AI, automation, and advanced analytics are accelerating cell and gene therapy manufacturing
- The policy and regulatory frameworks needed to support breakthrough platform technologies
- The future of U.S. biomanufacturing, supply chain resilience, and global competitiveness
- How patient experience is shaping the next generation of rare disease drug development and regulatory engagement

[Biotechnology Innovation Organization @IAmBiotech]

Upcoming webinar: Ahead of #BIO2026, join biotech leaders for a practical conversation on how to approach BIO Partnering™ with purpose. This is a fantastic opportunity to gain actionable insights that you can apply on the ground in San Diego: https://t.co/qD83GiwMRw

This webinar will cover how to:

-Prepare for BIO 2026 with a clear partnering strategy
-Understand what biopharma teams look for in licensing opportunities
-Position your science and data effectively
-Make the most of BIO Partnering™

[Biotechnology Innovation Organization @IAmBiotech]

As Dr. Rodino-Klapac noted, “The Ohio biotech ecosystem is what I dreamt of when I came here 26 years ago…It’s a great community and there’s no limit to what we can do in Ohio.”

[Biotechnology Innovation Organization @IAmBiotech]

The final stop in Columbus brought the BIO team to @Sarepta for a fireside chat between BIO President & CEO John F. Crowley and Dr. Louise Rodino-Klapac, Ph.D, president & head of R&D and technical operations for Sarepta.

Moderated by President & CEO of @OhioLifeScience Eddie Pauline, the discussion focused on the “man-made” barriers that can slow innovation reaching patients - and the shared responsibility to address them. The two also underscored why Ohio is uniquely positioned to lead in gene therapy and precision medicine, reflecting the strength of its research institutions and collaborative ecosystem.

#BIOontheAmericanRoad

[Biotechnology Innovation Organization @IAmBiotech]

Sarepta’s 140,000 sq ft Genetics Therapies Center of Excellence in Columbus - its primary R&D hub - anchors this work, advancing discovery, clinical development, and the transition to commercial-scale manufacturing, and reinforcing the critical role the Midwest - and Ohio - play in advancing U.S. biotechnology leadership.